S-1 · resale registration
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
XCUR$1.03+0.98%
Exicure, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$6.74M
Float & O/S:
Inst Own:
DilutionScan read 22 of EXICURE, INC.'s SEC filings and found 1 warrant series, 1 S-1 registration and 1 completed offering on file for XCUR. The latest dilution event on file is an offering on Sep 23, 2025. Analysis updated Oct 9, 2026.
Signal8 Summary
XCUR
Going-concern warning, cash nearly exhausted
Snapshot
Exicure is a micro-cap biotech with no revenue and a history of heavy losses: FY 2025 net loss was $4.9M, and the company burned $8.6M in free cash flow against just $1.7M in cash.
What's Happening Right Now
- : Nasdaq granted Exicure an extension through December 2, 2026 to regain compliance with the $2.5 million minimum stockholders' equity rule, but there's no assurance compliance will be achieved, and delisting could follow.
- : Exicure's Q2 2026 10-Q disclosed substantial doubt about its ability to continue as a going concern, with only $1.7M in cash, a fall below Nasdaq's minimum equity requirement, and a warning it could seek bankruptcy protection if it can't raise capital.
- : Exicure said it will issue about 172,058 shares to GPCR Therapeutics in August 2026 to settle a $1.0 million clinical milestone payment, using stock instead of cash to preserve its cash position.
Raise routes on file: effective S-1 · latest dilution event 406 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Sep 23, 2025 · Offering
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Effective
Warrant
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Offering
Issued 2025
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your XCUR trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
